Taiwan has targeted advanced therapy and digital health as its key elements for biomedical industry development. Besides a well-established infrastructure and biomedical clusters, the government has launched regulations to promote new sectors of biomedical industry, such as cell therapies, digiatl health, and CDMO. This presentation will update the progress for the biomedical ecosystem in Taiwan, including incentives for advancing together with Taiwanese partners.